Condition: Pulmonary Embolism (Diagnosis) · Pulmonary Embolism Acute · Pulmonary Embolism With Acute Cor Pulmonale · Sponsor: Sahlgrenska University Hospital
PURPOSE The two related purposes of the RE-TyPE study are: 1. To improve understanding of the early clinical course of intermediate-high risk pulmonary embolism and its association with outcome and 2. To establish a platform for longitudinal follow-up for all pulmonary embolism at Sahlgrenska University Hospital HYPOTHESES 1. The dynamic pattern of change, evaluated thorough repeated measures of biomarkers, electrocardiography and echocardiography during the first 48 hours after pulmonary embolism, better predicts outcome than static measurements currently used to predict outcome 2. Establishment of a platform for longitudinal follow-up will improve quality of care and outcome for patients with pulmonary embolism at Sahlgrenska University Hospital
This description comes directly from the study's public registry record.
Rickard Zeijlon, MD, PhD · +46313428884 · rickard.zeijlon@vgregion.se
Mazdak Tavoly, MD, PhD · +46313421000
Always discuss trial participation with your own doctor first.
| Sahlgrenska University Hospital/Mölndal | Gothenburg, Region Västra Götaland, Sweden | Not Yet Recruiting |
| Sahlgrenska University Hospital/Sahlgrenska | Gothenburg, Region Västra Götaland, Sweden | Recruiting |
| Sahlgrenska University Hospital/Östra | Gothenburg, Region Västra Götaland, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07491094